| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 10045368
[patent_doc_number] => 09085756
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-07-21
[patent_title] => 'Drug screening using islet cells and islet cell progenitors from human embryonic stem cells'
[patent_app_type] => utility
[patent_app_number] => 12/762676
[patent_app_country] => US
[patent_app_date] => 2010-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 13813
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12762676
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/762676 | Drug screening using islet cells and islet cell progenitors from human embryonic stem cells | Apr 18, 2010 | Issued |
Array
(
[id] => 6549715
[patent_doc_number] => 20100233143
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-16
[patent_title] => 'Parthenogenic Activation of Human Oocytes for the Production of Human Embryonic Stem Cells'
[patent_app_type] => utility
[patent_app_number] => 12/759654
[patent_app_country] => US
[patent_app_date] => 2010-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 47767
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0233/20100233143.pdf
[firstpage_image] =>[orig_patent_app_number] => 12759654
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/759654 | Parthenogenic Activation of Human Oocytes for the Production of Human Embryonic Stem Cells | Apr 12, 2010 | Abandoned |
Array
(
[id] => 6396888
[patent_doc_number] => 20100304481
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-02
[patent_title] => 'MEDIUM AND CULTURE OF EMBRYONIC STEM CELLS'
[patent_app_type] => utility
[patent_app_number] => 12/754574
[patent_app_country] => US
[patent_app_date] => 2010-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 13586
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0304/20100304481.pdf
[firstpage_image] =>[orig_patent_app_number] => 12754574
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/754574 | Primate pluripotent stem cells cultured in medium containing gamma-aminobutyric acid, pipecolic acid and lithium | Apr 4, 2010 | Issued |
Array
(
[id] => 6339763
[patent_doc_number] => 20100247499
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-30
[patent_title] => 'hUTC AS THERAPY FOR ALZHEIMER\'S DISEASE'
[patent_app_type] => utility
[patent_app_number] => 12/748170
[patent_app_country] => US
[patent_app_date] => 2010-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 34708
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0247/20100247499.pdf
[firstpage_image] =>[orig_patent_app_number] => 12748170
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/748170 | hUTC as therapy for Alzheimer's disease | Mar 25, 2010 | Issued |
Array
(
[id] => 8171267
[patent_doc_number] => 20120107286
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-03
[patent_title] => 'PLURIPOTENT STEM CELLS'
[patent_app_type] => utility
[patent_app_number] => 13/259668
[patent_app_country] => US
[patent_app_date] => 2010-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 10535
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0107/20120107286.pdf
[firstpage_image] =>[orig_patent_app_number] => 13259668
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/259668 | Induced pluripotent stem cell produced by transfecting a human neural stem cell with an episomal vector encoding the Oct4 and Nanog proteins | Mar 23, 2010 | Issued |
Array
(
[id] => 8054045
[patent_doc_number] => 20120076762
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-29
[patent_title] => 'INDUCED PLURIPOTENT STEM CELL GENERATION USING TWO FACTORS AND P53 INACTIVATION'
[patent_app_type] => utility
[patent_app_number] => 13/259644
[patent_app_country] => US
[patent_app_date] => 2010-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 14940
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20120076762.pdf
[firstpage_image] =>[orig_patent_app_number] => 13259644
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/259644 | INDUCED PLURIPOTENT STEM CELL GENERATION USING TWO FACTORS AND P53 INACTIVATION | Mar 23, 2010 | Abandoned |
Array
(
[id] => 6527462
[patent_doc_number] => 20100212032
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-19
[patent_title] => 'Compositions and Methods for the Efficient and Reproducible Generation of Clone Animals of All Developmental Stages and Methods of Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 12/729325
[patent_app_country] => US
[patent_app_date] => 2010-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 14499
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0212/20100212032.pdf
[firstpage_image] =>[orig_patent_app_number] => 12729325
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/729325 | Hypertonic conditions for cell and oocyte enucleation | Mar 22, 2010 | Issued |
Array
(
[id] => 6196779
[patent_doc_number] => 20110028537
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-03
[patent_title] => 'SOMATIC CELL REPROGRAMMING'
[patent_app_type] => utility
[patent_app_number] => 12/727061
[patent_app_country] => US
[patent_app_date] => 2010-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 12287
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20110028537.pdf
[firstpage_image] =>[orig_patent_app_number] => 12727061
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/727061 | Composition comprising recombinant nucleic acid encoding Sox2, Oct-4, Nanog and Lin28 | Mar 17, 2010 | Issued |
Array
(
[id] => 6540175
[patent_doc_number] => 20100287633
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-11
[patent_title] => 'Hyperactive PiggyBac Transposases'
[patent_app_type] => utility
[patent_app_number] => 12/712504
[patent_app_country] => US
[patent_app_date] => 2010-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 18603
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0287/20100287633.pdf
[firstpage_image] =>[orig_patent_app_number] => 12712504
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/712504 | Nucleic acids encoding hyperactive PiggyBac transposases | Feb 24, 2010 | Issued |
Array
(
[id] => 9850073
[patent_doc_number] => 08951800
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-02-10
[patent_title] => 'Primate pluripotent stem cell expansion without feeder cells and in the presence of FGF and matrigel or Engelbreth-Holm-Swarm tumor cell preparation'
[patent_app_type] => utility
[patent_app_number] => 12/710078
[patent_app_country] => US
[patent_app_date] => 2010-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 15216
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12710078
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/710078 | Primate pluripotent stem cell expansion without feeder cells and in the presence of FGF and matrigel or Engelbreth-Holm-Swarm tumor cell preparation | Feb 21, 2010 | Issued |
Array
(
[id] => 9850073
[patent_doc_number] => 08951800
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-02-10
[patent_title] => 'Primate pluripotent stem cell expansion without feeder cells and in the presence of FGF and matrigel or Engelbreth-Holm-Swarm tumor cell preparation'
[patent_app_type] => utility
[patent_app_number] => 12/710078
[patent_app_country] => US
[patent_app_date] => 2010-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 15216
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12710078
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/710078 | Primate pluripotent stem cell expansion without feeder cells and in the presence of FGF and matrigel or Engelbreth-Holm-Swarm tumor cell preparation | Feb 21, 2010 | Issued |
Array
(
[id] => 6294795
[patent_doc_number] => 20100240090
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-23
[patent_title] => 'METHODS AND PLATFORMS FOR DRUG DISCOVERY'
[patent_app_type] => utility
[patent_app_number] => 12/709379
[patent_app_country] => US
[patent_app_date] => 2010-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 30839
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0240/20100240090.pdf
[firstpage_image] =>[orig_patent_app_number] => 12709379
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/709379 | METHODS AND PLATFORMS FOR DRUG DISCOVERY | Feb 18, 2010 | Abandoned |
Array
(
[id] => 7800917
[patent_doc_number] => 08129187
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-03-06
[patent_title] => 'Somatic cell reprogramming by retroviral vectors encoding Oct3/4. Klf4, c-Myc and Sox2'
[patent_app_type] => utility
[patent_app_number] => 12/656907
[patent_app_country] => US
[patent_app_date] => 2010-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 57
[patent_figures_cnt] => 57
[patent_no_of_words] => 29455
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/129/08129187.pdf
[firstpage_image] =>[orig_patent_app_number] => 12656907
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/656907 | Somatic cell reprogramming by retroviral vectors encoding Oct3/4. Klf4, c-Myc and Sox2 | Feb 17, 2010 | Issued |
Array
(
[id] => 6500445
[patent_doc_number] => 20100210014
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-19
[patent_title] => 'Nuclear reprogramming factor and induced pluripotent stem cells'
[patent_app_type] => utility
[patent_app_number] => 12/656908
[patent_app_country] => US
[patent_app_date] => 2010-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 58
[patent_figures_cnt] => 58
[patent_no_of_words] => 29455
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0210/20100210014.pdf
[firstpage_image] =>[orig_patent_app_number] => 12656908
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/656908 | Nuclear reprogramming factor and induced pluripotent stem cells | Feb 17, 2010 | Abandoned |
Array
(
[id] => 7811195
[patent_doc_number] => 08133725
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-03-13
[patent_title] => 'Bone marrow stromal cells comprising a nucleic acid encoding a notch intracellular domain'
[patent_app_type] => utility
[patent_app_number] => 12/658104
[patent_app_country] => US
[patent_app_date] => 2010-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 59
[patent_no_of_words] => 13413
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/133/08133725.pdf
[firstpage_image] =>[orig_patent_app_number] => 12658104
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/658104 | Bone marrow stromal cells comprising a nucleic acid encoding a notch intracellular domain | Feb 1, 2010 | Issued |
Array
(
[id] => 8543197
[patent_doc_number] => 08318486
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-11-27
[patent_title] => 'Co-culturing mammalian embryonic stem cells with human foreskin fibroblasts'
[patent_app_type] => utility
[patent_app_number] => 12/695199
[patent_app_country] => US
[patent_app_date] => 2010-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 16
[patent_no_of_words] => 10240
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12695199
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/695199 | Co-culturing mammalian embryonic stem cells with human foreskin fibroblasts | Jan 27, 2010 | Issued |
Array
(
[id] => 6228832
[patent_doc_number] => 20100183570
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-22
[patent_title] => 'NON-EMBRYONIC STEM CELLS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/686584
[patent_app_country] => US
[patent_app_date] => 2010-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 10847
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0183/20100183570.pdf
[firstpage_image] =>[orig_patent_app_number] => 12686584
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/686584 | Producing a mammalian pluripotent cell population from mammalian blastomere-like stem cells (BLSCs) | Jan 12, 2010 | Issued |
Array
(
[id] => 6235431
[patent_doc_number] => 20100267135
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-21
[patent_title] => 'MULTIPOTENT/PLURIPOTENT CELLS AND METHODS'
[patent_app_type] => utility
[patent_app_number] => 12/685569
[patent_app_country] => US
[patent_app_date] => 2010-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 115774
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0267/20100267135.pdf
[firstpage_image] =>[orig_patent_app_number] => 12685569
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/685569 | MULTIPOTENT/PLURIPOTENT CELLS AND METHODS | Jan 10, 2010 | Abandoned |
Array
(
[id] => 10522912
[patent_doc_number] => 09249412
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-02-02
[patent_title] => 'Simplified method for partial genetic and epigenetic reprogramming of cells using siRNA specific for a heterochromatin protein 1'
[patent_app_type] => utility
[patent_app_number] => 13/146158
[patent_app_country] => US
[patent_app_date] => 2010-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5575
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 164
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13146158
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/146158 | Simplified method for partial genetic and epigenetic reprogramming of cells using siRNA specific for a heterochromatin protein 1 | Jan 6, 2010 | Issued |
Array
(
[id] => 6626061
[patent_doc_number] => 20100172863
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-08
[patent_title] => 'Enhanced medical implant'
[patent_app_type] => utility
[patent_app_number] => 12/655633
[patent_app_country] => US
[patent_app_date] => 2010-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 21036
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0172/20100172863.pdf
[firstpage_image] =>[orig_patent_app_number] => 12655633
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/655633 | Enhanced medical implant comprising disrupted tooth pulp and tooth particles | Jan 3, 2010 | Issued |